Largest US Stock Movers — October 16, 2026
Query: top movers today · data as of 2026-10-16
Rebuilt the October 16, 2026 movers screen: Top Gainers (25 names, led by energy/E&P) and Top Losers (25 names, led by AI-infrastructure/neocloud, clinical biotech and crypto-adjacent financiers) on a sharply negative breadth tape (1,079 advancers vs 1,914 decliners, avg stock -1.36%). Added all requested columns plus fresh row commentary and a market-context narrative.
Daily movers for the October 16, 2026 session: a broad de-risking tape (1,079 advancers vs 1,914 decliners, average stock -1.36%). Gainers are dominated by oil & gas E&P as crude bids up; losers cluster in biotech, AI-infrastructure/neocloud and crypto-adjacent financiers.
What the Movers Are Telling Us
Reading the tape (October 16, 2026)
Breadth was decisively negative — 1,079 advancers against 1,914 decliners, with the average US stock down 1.36%. That framing matters more than any single name: the gainer list is not a risk-on signal, it is a narrow commodity-driven pocket of strength inside a session where bids were being withdrawn almost everywhere else.
The upside is an energy tape, not a growth tape
Roughly two-thirds of the top-gainer table is oil & gas — E&P, non-operated working-interest owners, and one NGL midstream. Energy was the only large sector with a real bid, and crude itself leads the broader commodity complex. These are cash-flow stories being bought as ballast: dividend-paying producers with modest valuations, royalty-style models that pass hydrocarbon prices straight through to earnings, and names that pay out rather than reinvest at rising hurdle rates. That is why the one- and six-month columns on the gainers look durable rather than like a single-session squeeze. The standout exceptions are instructive — a volatility ETN (a hedge working, not a company growing), a recently listed Japanese payments platform bouncing inside a post-IPO drawdown, and a beaten-up nutrition brand drawing value buyers in staples.
The downside is liquidity-shaped
On the loser side the pattern is not one sector but one profile: high-beta, pre-profit, or balance-sheet-levered. Three clusters stand out. AI infrastructure — neoclouds, GPU-hosting and data-center developers — is re-pricing around the cost and availability of project debt rather than around demand; the group's bellwether is the single most important read on the complex. Clinical-stage biotech is being treated as optionality and sold first, with near-term catalysts turning these names into event binaries. And crypto-linked financiers and miners are falling with digital-asset sentiment while carrying the added AI-hosting exposure. An Indonesian telecom ADR shows a fourth, index-flow-driven mechanism rather than a company-specific one.
How to use these tables
Treat the gainers as a momentum watchlist levered to crude — it holds only while energy leadership holds. Treat the losers as a triage list: a double-digit drop in a profitable, well-capitalized business is a different opportunity from the same drop in a cash-burning one. Relative volume near or above 2x on a down day is usually genuine distribution rather than noise, and the % from 52-week high column separates fresh breakdowns from names already washed out.
Top Gainers
| Symbol | Security Name | Sector | Industry | 1D Return | 1M Return | 6M Return | Market Cap | Relative Volume | Momentum Potential | P/E (TTM) | Days Since Earnings | % From 52W High | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IAM | Iambic Therapeutics, Inc. - Common Stock | Health Care | Biotechnology | 25.91% | — | — | 8.963e+08 | 1.1882 | — | — | — | 0.00% | Recent IPO in the metabolic/machine-learning drug design space; no pricing history yet, so today's jump is a thin-float move rather than a broad biotech bid. Illiquid and news-sensitive — position sizing matters more than the print. |
| CRGY | Crescent Energy Company | Energy | Oil & Gas E&P | 10.07% | -2.41% | 18.85% | 5.417e+09 | 2.9584 | 61 | 172.13 | 73 | -10.41% | Acquisitive consolidator of legacy oil & gas assets with a capital-markets-driven model; its beta to crude is amplified by leverage, so rallies like this tend to overshoot both ways. |
| VXX | iPath Series B S&P 500 VIX Short-Term Futures ETN | — | — | 7.61% | 3.67% | -36.58% | 5.01e+08 | 5.0368 | 3.2 | 0.08 | — | -54.02% | A volatility ETN, not an operating company — gains here are a hedge working, i.e. the market paying up for protection. Structural roll decay in futures means it loses ground whenever calm returns. |
| GRNT | Granite Ridge Resources, Inc. | Energy | Oil & Gas E&P | 7.07% | 10.32% | 15.12% | 7.189e+08 | 1.2888 | 36.7 | 30.28 | 70 | -10.80% | Non-operated Permian/North Dakota working-interest owner: a high-payout royalty-style model that passes crude and gas prices straight to the income statement, which explains the outsized reaction versus larger peers. |
| MTDR | Matador Resources Company | Energy | Oil & Gas E&P | 6.97% | -0.26% | 2.25% | 7.118e+09 | 1.0191 | 54.3 | 9.87 | 71 | -12.12% | Delaware Basin producer that has been leaning into midstream and M&A; debt-adjusted cash flow is highly levered to oil, and it screens cheap on earnings for a grower, a common E&P re-rating candidate when crude firms. |
| PAYP | PayPay Corporation - American D | Information Technology | Software - Infrastructure | 6.96% | -12.45% | -27.41% | 1.062e+10 | 1.509 | — | — | 77 | -36.16% | Japan's dominant mobile-payments platform, recently listed in New York. A bounce inside a post-IPO drawdown — the thesis is cashless-payment share gain in Japan; the risk is thin float and lockup-event volatility. |
| AR | Antero Resources Corporation | Energy | Oil & Gas E&P | 6.06% | 8.60% | 5.37% | 1.188e+10 | 1.309 | 35.3 | 11.07 | 78 | -14.40% | Pure-play Appalachian natural gas and NGL producer with heavy liquids exposure; the name is a high-torque bet on gas prices, which have been the stronger leg of the energy complex recently. |
| HPK | HighPeak Energy, Inc. - Common Stock | Energy | Oil & Gas E&P | 6.03% | 26.50% | 97.38% | 1.334e+09 | 1.916 | 62.5 | 75.36 | 66 | 0.00% | Small-cap Permian operator with a concentrated acreage position; the market is paying for its takeout optionality as much as for oil — asset-level M&A in the basin is the recurring catalyst. |
| NOG | Northern Oil and Gas, Inc. | Energy | Oil & Gas E&P | 5.48% | 9.95% | 15.53% | 2.894e+09 | 0.7741 | 77.6 | 69.64 | 70 | -11.88% | Non-operated working-interest aggregator that functions as a diversified, fee-light royalty on other operators' drilling programs. High momentum score reflects steady cash returns and low operational risk. |
| SM | SM Energy Company | Energy | Oil & Gas E&P | 5.28% | 6.84% | 54.05% | 9.395e+09 | 0.7608 | 84.5 | 7 | 71 | -4.34% | Permian and Eagle Ford producer that pivoted to debt reduction and buybacks after its acquisitions; one of the cleaner shareholder-return stories in E&P, so strength here is supported by capital allocation, not just the commodity. |
| NEWP | New Pacific Metals Corp. Common Shares | Materials | Silver | 5.13% | 11.38% | 19.49% | 7.773e+08 | 1.1722 | 93.6 | — | 42 | -11.47% | Bolivian silver developer — a leveraged play on precious-metal prices rather than earnings. High momentum score, but the fundamental risk is mine permitting and financing, not the metal. |
| BRBR | BellRing Brands, Inc. | Consumer Staples | Packaged Foods | 4.89% | 3.51% | -40.88% | 1.097e+09 | 1.415 | 10.3 | 6.64 | 73 | -72.84% | Protein-shake and nutrition brand (Premier Protein, Dymatize) in a deep drawdown after growth decelerated; a bounce in a staples name on a down tape reads as value hunting in a beaten-up, still-profitable consumer franchise. |
| OVV | Ovintiv Inc. (DE) | Energy | Oil & Gas E&P | 4.84% | 10.07% | 32.58% | 1.918e+10 | 1.0639 | 36.3 | 19.37 | 84 | 0.00% | Large-cap Permian and Montney producer that has been a serial acquirer; one of the more liquid ways institutional money expresses a bullish crude view, which is why it leads on energy up-days. |
| VTS | Vitesse Energy, Inc. | Energy | Oil & Gas E&P | 4.82% | 2.82% | 8.07% | 7.684e+08 | 1.0977 | 27.3 | 28.52 | 73 | -19.78% | Non-operated Bakken-focused producer paying a meaningful monthly dividend — a yield vehicle inside energy, favoured when investors want cash flow over growth. |
| MUR | Murphy Oil Corporation | Energy | Oil & Gas E&P | 4.74% | 10.75% | 15.36% | 5.983e+09 | 0.9036 | 38.3 | 20.66 | 71 | -2.34% | Offshore Gulf of Mexico and Eagle Ford producer with an offshore-growth narrative; results are lumpy with project timing, and the stock trades at a discount to onshore peers on reserve-life concerns. |
| OIG | Orion180 Insurance Group Inc. - Class A Common Stock | Financials | Insurance - Property & Casualty | 4.70% | — | — | 1.127e+09 | 0.2279 | — | — | — | -17.84% | Recently listed Florida-focused property & casualty insurer with a specialty coastal-risk book. Freshly public, thin float — moves are supply-driven and the CAT-loss exposure is the key underwriting risk. |
| TALO | Talos Energy, Inc. | Energy | Oil & Gas E&P | 4.65% | 3.62% | 31.63% | 2.967e+09 | 2.649 | 28.4 | — | 72 | -3.06% | Gulf of Mexico pure-play that has been integrating acquisitions; free cash flow is highly geared to oil and the equity is a leveraged expression of offshore project execution. |
| SRTA | Strata Critical Medical, Inc. - Class A Common Stock | Health Care | Medical Care Facilities | 4.61% | -15.61% | -0.66% | 4.016e+08 | 1.6735 | 25.1 | 9.08 | 73 | -29.83% | Recently spun/split-out critical-care hospital operator trading well below its reference level; the bounce is a stabilization attempt after a severe post-listing drawdown, with reimbursement and staffing as the swing factors. |
| EQNR | Equinor ASA | Energy | Oil & Gas Integrated | 4.59% | 5.98% | 35.10% | 8.063e+10 | 1.2806 | 64.4 | 12.73 | 86 | 0.00% | Norwegian state-backed integrated major — the international, dividend-paying way to own energy leadership; benefits from European gas pricing and a weaker dollar as much as from crude. |
| FMX | Fomento Economico Mexicano S.A. | Consumer Staples | Beverages - Brewers | 4.52% | 6.61% | 12.29% | 4.308e+10 | 3.2028 | 33.8 | 24.6 | 80 | -5.04% | Mexican bottler/retail conglomerate (Coca-Cola FEMSA, OXXO); strength reflects peso and Mexico equity performance plus a defensive staples bid, not commodity exposure. Large-cap, liquid, low-beta ballast. |
| DNOW | DNOW Inc. | Industrials | Industrial Distribution | 4.39% | -1.69% | 31.21% | 2.835e+09 | 1.7778 | 32.9 | — | 71 | -7.05% | Oilfield and industrial PVF distributor — a services-adjacent way to own an energy capex upcycle. Also sensitive to general industrial demand, so it participates in energy strength with less direct commodity beta. |
| TRGP | Targa Resources, Inc. | Energy | Oil & Gas Midstream | 4.37% | 3.45% | 26.44% | 6.324e+10 | 0.9366 | 56.7 | 28.22 | 71 | -2.43% | Largest pure-play NGL midstream with fee-based gathering and processing; benefits from rising gas/NGL volumes regardless of the crude price direction, one of the steadiest cash-flow compounders in the complex. |
| OBE | Obsidian Energy Ltd. | Energy | Oil & Gas E&P | 4.36% | -1.32% | 18.51% | 6.177e+08 | 0.8399 | 37.4 | 39.9 | 78 | -17.22% | Canadian heavy-oil producer with a Peace River focus; a beta-heavy, leveraged play on Western Canadian Select spreads and energy sentiment. |
| VET | Vermilion Energy Inc. | Energy | Oil & Gas E&P | 4.35% | 4.35% | 16.84% | 1.506e+09 | 0.8633 | 45 | — | 79 | -8.46% | International E&P with European and Canadian gas plus Australian assets; a dividend payer that captures the gas-price leg of the energy rally and offers geographic diversification away from US shale. |
| RRC | Range Resources Corporation | Energy | Oil & Gas E&P | 4.35% | 10.54% | 4.14% | 1.01e+10 | 0.9582 | 69.9 | 11.94 | 86 | -9.30% | Appalachian gas pure-play with the lowest-cost position among US gas producers; strong momentum reflects new LNG and power-demand contracts for its molecules, making it more than a simple commodity trade. |
Top Losers
| Symbol | Security Name | Sector | Industry | 1D Return | 1M Return | 6M Return | Market Cap | Relative Volume | Momentum Potential | P/E (TTM) | Days Since Earnings | % From 52W High | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RXRX | Recursion Pharmaceuticals, Inc. - Class A Common Stock | Health Care | Biotechnology | -16.71% | -2.12% | -8.33% | 1.858e+09 | 1.8619 | 17.6 | — | 72 | -48.13% | AI-driven drug discovery platform burning cash with no approved product — its valuation is a long-duration bet on the platform, which is exactly the profile hurt most when cost of capital rises. Risk is further financing dilution. |
| BSP | Bending Spoons S.p.A. | Information Technology | Software - Application | -15.60% | 22.10% | — | 2.627e+10 | 2.0355 | — | — | 64 | -15.60% | Italian software acquirer listed in New York, still a very recent IPO. Pullback after a strong post-listing run; lockup and float dynamics, not fundamentals, drive short-term swings. |
| SHAZ | SharonAI Holdings, Inc. - Class A Common Stock | Information Technology | Information Technology Services | -14.31% | -53.13% | -28.17% | 9.52e+08 | 1.3246 | 27.4 | — | 70 | -71.32% | Small-cap AI/HPC infrastructure and data-center compute provider caught in the neocloud de-rating; the business model depends on financing GPU capacity faster than depreciation catches up — the key risk is capital structure, not demand. |
| GLAS | Glass House Brands Inc. Subordi | Health Care | Drug Manufacturers - Specialty & Generic | -14.02% | -60.08% | -61.60% | 3.006e+08 | 1.9902 | 0.1 | — | 60 | -76.51% | US cannabis cultivator and retailer with a leveraged balance sheet. The collapse is a financing/liquidity event in a sector where federal rescheduling hopes keep fading — value is trapped until capital markets reopen. |
| OMER | Omeros Corporation | Health Care | Biotechnology | -13.78% | -12.20% | 20.54% | 1.173e+09 | 2.2268 | 89.9 | 9.82 | 64 | -23.04% | Clinical-stage biotech with a complement inhibitor for rare kidney disease; with a near-term catalyst pending, the stock is being traded as an event binary, so today's move is positioning ahead of data rather than a business change. |
| TLK | PT Telekomunikasi Indonesia, Tb | Communication Services | Telecom Services | -13.69% | -22.54% | -35.44% | 1.478e+10 | 8.0389 | 15.4 | 11.03 | — | -52.92% | Indonesian state-linked telecom ADR hit by index-flow pressure after MSCI's Indonesia reclassification — an index-driven sale, not a company-specific deterioration. Structural risk is EM passive outflows and FX. |
| KOPN | Kopin Corporation - Common Stock | Information Technology | Electronic Components | -13.65% | -30.44% | 10.40% | 5.942e+08 | 1.796 | 14.6 | — | 186 | -48.51% | Microdisplay and micro-LED component maker with defense/AR optionality; a micro-cap with lumpy orders and persistent losses — the kind of speculative name that gets sold first in a liquidity-driven de-risking. |
| FOXF | Fox Factory Holding Corp. | Consumer Discretionary | Auto Parts | -13.30% | -17.23% | -7.66% | 6.742e+08 | 4.5579 | 17.6 | — | 70 | -35.53% | Suspension and component supplier to bike, off-road and auto OEMs; deleveraging and weak discretionary end-markets have squeezed margins. A levered consumer-discretionary cyclical in a tape that is punishing both traits. |
| BLZE | Backblaze, Inc. | Information Technology | Software - Infrastructure | -13.22% | -37.64% | 109.76% | 5.323e+08 | 1.201 | 84.2 | — | 73 | -57.91% | Object-storage cloud provider competing with hyperscalers on price; it has an AI-data-storage narrative but is still unprofitable, so it trades with the neocloud/AI-compute complex. Financing cost is the binding constraint. |
| SECZ | Securitize Corp. | Information Technology | Software - Application | -13.05% | 10.41% | — | 1.61e+09 | 1.0339 | — | — | 64 | -40.71% | Tokenization and digital-asset infrastructure company; falls with crypto sentiment and with anything involving token issuers' risk appetite. Rallies and drawdowns here are tightly correlated to digital-asset liquidity. |
| GRAL | GRAIL, Inc. - Common Stock | Health Care | Diagnostics & Research | -13.03% | 47.35% | 127.83% | 5.262e+09 | 1.2908 | 92.6 | — | 71 | -23.54% | Multi-cancer early detection test developer with a strong recent run on commercial progression — this looks like profit-taking in a high-expectation healthcare growth name rather than a thesis break. |
| VICR | Vicor Corporation | Information Technology | Electronic Components | -12.92% | -11.50% | -12.18% | 8.829e+09 | 2.1176 | 83.9 | 61.18 | 87 | -49.58% | Power-module and advanced packaging maker tied to AI data-center power delivery; a profitable, premium-multiple hardware name getting caught in the AI capex valuation reset. Order book is the thing to watch. |
| DNA | Ginkgo Bioworks Holdings, Inc. Class A Common Stock | Health Care | Biotechnology | -12.67% | 30.99% | 27.90% | 6.916e+08 | 1.729 | 50.5 | — | 71 | -32.08% | Synthetic-biology foundry transitioning to its own programs after pivoting away from a services model; still cash-burning, so any AI-adjacent growth name without near-term earnings is vulnerable. |
| BAND | Bandwidth Inc. | Information Technology | Software - Infrastructure | -12.62% | -14.20% | 88.35% | 1.395e+09 | 1.2111 | 55.3 | — | 79 | -44.75% | CPaaS provider for voice and emergency services; levered, low-margin and competitively pressured, with growth tied to enterprise communications spend. The move reflects a risk-off view of small software balance sheets. |
| AEHR | Aehr Test Systems | Information Technology | Semiconductor Equipment & Materials | -12.44% | -33.08% | -27.74% | 1.979e+09 | 1.3185 | 4.6 | — | 93 | -58.38% | Semiconductor test equipment for burn-in and HBM/memory production; historically a highly cyclical small cap whose orders swing with memory capex, so a sharp drop after a big run is classic — the rig counts, not today's tape, matter. |
| NBIS | Nebius Group N.V. | Communication Services | Internet Content & Information | -12.18% | -24.09% | 5.30% | 4.498e+10 | 1.6527 | 68.5 | — | 65 | -42.28% | European AI cloud/GPU provider and one of the largest neocloud balance sheets; directly hit by the bond-market squeeze on AI infrastructure financing. Demand is not the concern — the cost and availability of debt are. |
| NVAX | Novavax, Inc. - Common Stock | Health Care | Biotechnology | -12.17% | 12.60% | 27.38% | 1.857e+09 | 1.6231 | 87 | 4.36 | 71 | -12.17% | Vaccine developer dependent on partnerships and government contracts for its updated shots; a low-priced, high-beta name with heavy retail participation, so the drawdown is amplified by flows around policy and seasonal demand. |
| SLS | SELLAS Life Sciences Group, Inc. - Common Stock | Health Care | Biotechnology | -11.99% | -13.44% | 91.19% | 2.015e+09 | 2.4327 | 85.1 | — | 65 | -35.45% | Late-stage oncology biotech with a lead AML/gynecologic asset; microcap clinical risk plus financing risk — a name whose daily moves are dictated by catalyst timing, not by the broad market. |
| CRWV | CoreWeave, Inc. - Class A Common Stock | Information Technology | Software - Infrastructure | -11.91% | -23.15% | -47.46% | 3.386e+10 | 2.8661 | 22.3 | — | 65 | -56.69% | The bellwether for AI compute financing: heavily debt-funded GPU capacity and customer concentration. Its weakness spreads to the entire neocloud/AI-adjacent complex — many names further down the list are trading as derivatives of this. |
| BRUN | Boost Run Inc. | Information Technology | Software - Infrastructure | -11.81% | -46.70% | -37.39% | 7.066e+08 | 1.642 | 22.7 | — | 58 | -77.32% | Micro-cap AI/software infrastructure name that has been among the most eroded speculative plays; liquidity in the stock itself, not the business, now drives the price. |
| GLXY | Galaxy Digital Inc. | Financials | Capital Markets | -11.56% | -27.56% | -37.54% | 9.511e+09 | 1.4658 | 17.1 | — | 72 | -62.34% | Digital-asset financial services firm with crypto mining, trading and AI-HPC data-center ambitions; its equity is a high-beta proxy for bitcoin and for the AI financing market simultaneously — a double exposure in a risk-off session. |
| RIOT | Riot Platforms, Inc. - Common Stock | Financials | Capital Markets | -11.48% | -37.29% | -24.24% | 5.149e+09 | 0.8579 | 0.5 | — | 66 | -52.18% | Bitcoin miner pivoting capacity toward AI/HPC hosting; valuation is now a mix of hash-price beta and data-center contract hopes, both of which are under pressure. Higher energy costs add a second squeeze on margins. |
| APLD | Applied Digital Corporation | Information Technology | Information Technology Services | -11.48% | -31.58% | -42.75% | 5.458e+09 | 1.7536 | 4.4 | — | 8 | -63.65% | Data-center developer that leases capacity to hyperscalers — the purest expression of the AI build-out financing story on the list, and the most sensitive to the cost of project debt. |
| PGEN | Precigen, Inc. - Common Stock | Health Care | Biotechnology | -11.32% | -18.87% | 60.43% | 2.286e+09 | 1.0559 | 42.5 | — | 72 | -25.41% | Gene-therapy biotech commercializing a first-in-class asset; small-cap clinical/commercial risk plus prior dilutive financings make it a casualty of the general withdrawal from pre-profit healthcare. |
| SDGR | Schrodinger, Inc. - Common Stock | Health Care | Health Information Services | -11.30% | -25.26% | 83.14% | 1.691e+09 | 1.3984 | 90.2 | — | 71 | -30.67% | Physics-based drug discovery software and drug-program developer; the platform thesis stays intact but it is unprofitable and rate-sensitive, and the move shows how quickly the AI-biotech narrative loses its bid. |
Run a version of this yourself
Describe the idea in plain English and Relaxfolio returns a researchable shortlist with the charts, fundamentals, and risks attached.
Educational research tool — not investment advice. A screen is a starting point, not a recommendation.